Login / Signup
Is tirzepatide in the surpass lane over GLP-1 receptor agonists for the treatment of diabetes?
Francesco Paneni
Carlo Patrono
Published in:
European heart journal (2021)
Keyphrases
</>
type diabetes
cardiovascular disease
metabolic syndrome
replacement therapy